Paper3125849
Isolation of type 5 capsular polysaccharide from Staphylococcus aureus.
Fournier JM and 4 others. Ann Inst Pasteur Microbiol, 1987. Cited by 43 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Isolation of type 5 capsular polysaccharide from Staphylococcus aureus. Papers, record 3125849. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3125849
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Capsules | Major topic |
| Polysaccharides, Bacterial | Major topic |
| Staphylococcus aureus | Major topic |
| Chromatography, Gas | |
| Chromatography, Gel | |
| Chromatography, Ion Exchange | |
| Electrophoresis, Paper | |
| Humans | |
| Immunodiffusion | |
| Magnetic Resonance Spectroscopy |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,823,959 | Synthesis, Conformal Analysis, and Antibody Binding of Staphylococcus aureus Capsular Polysaccharide Type 5 Oligosaccharides. | Angew Chem Int Ed Engl | 2025 | https://conductscience.org/library/papers/40823959 | PubMed |
| 33,522,395 | Pathogenicity and virulence of Staphylococcus aureus. | Virulence | 2021 | https://conductscience.org/library/papers/33522395 | PubMed |
| 31,133,995 | Absence of Protein A Expression Is Associated With Higher Capsule Production in Staphylococcal Isolates. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31133995 | PubMed |
| 29,382,968 | Biological characteristics and conjugated antigens of ClfA A-FnBPA and CP5 in Staphylococcus aureus. | Can J Vet Res | 2018 | https://conductscience.org/library/papers/29382968 | PubMed |
| 19,273,563 | Campylobacter jejuni cocultured with epithelial cells reduces surface capsular polysaccharide expression. | Infect Immun | 2009 | https://conductscience.org/library/papers/19273563 | PubMed |
| 14,726,462 | Staphylococcus aureus capsular polysaccharides. | Clin Microbiol Rev | 2004 | https://conductscience.org/library/papers/14726462 | PubMed |
| 9,746,554 | Antigenic determinants of Staphylococcus aureus type 5 and type 8 capsular polysaccharide vaccines. | Infect Immun | 1998 | https://conductscience.org/library/papers/9746554 | PubMed |
| 8,613,375 | A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. | Infect Immun | 1996 | https://conductscience.org/library/papers/8613375 | PubMed |
| 8,478,074 | Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus. | Infect Immun | 1993 | https://conductscience.org/library/papers/8478074 | PubMed |
| 8,432,841 | Type 5 and 8 capsular polysaccharides are expressed by Staphylococcus aureus isolates from rabbits, poultry, pigs, and horses. | J Clin Microbiol | 1993 | https://conductscience.org/library/papers/8432841 | PubMed |
| 8,432,807 | Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: resolution of clonal relationships. | J Clin Microbiol | 1993 | https://conductscience.org/library/papers/8432807 | PubMed |
| 8,406,887 | Phase variation of slime production in Staphylococcus aureus: implications in colonization and virulence. | Infect Immun | 1993 | https://conductscience.org/library/papers/8406887 | PubMed |
| 7,697,524 | Effects of culture conditions on production of type 5 capsular polysaccharide by human and bovine Staphylococcus aureus strains. | Clin Diagn Lab Immunol | 1995 | https://conductscience.org/library/papers/7697524 | PubMed |
| 3,230,130 | Staphylococcus aureus capsular types and antibody response to lung infection in patients with cystic fibrosis. | J Clin Microbiol | 1988 | https://conductscience.org/library/papers/3230130 | PubMed |
| 2,745,705 | Direct testing of blood culture for detection of the serotype 5 and 8 capsular polysaccharides of Staphylococcus aureus. | J Clin Microbiol | 1989 | https://conductscience.org/library/papers/2745705 | PubMed |
| 2,312,680 | Reactivity of coagulase-negative staphylococci isolated from cow and goat milk with monoclonal antibodies to Staphylococcus aureus capsular polysaccharide types 5 and 8. | J Clin Microbiol | 1990 | https://conductscience.org/library/papers/2312680 | PubMed |
| 2,229,349 | Phagocytosis of mastitis isolates of Staphylococcus aureus and expression of type 5 capsular polysaccharide are influenced by growth in the presence of milk. | J Clin Microbiol | 1990 | https://conductscience.org/library/papers/2229349 | PubMed |
| 2,199,498 | Epidemiological markers for epidemic strain and carrier isolates in an outbreak of nosocomial oxacillin-resistant Staphylococcus aureus. | J Clin Microbiol | 1990 | https://conductscience.org/library/papers/2199498 | PubMed |
| 2,114,365 | Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A. | Infect Immun | 1990 | https://conductscience.org/library/papers/2114365 | PubMed |
| 2,014,996 | Staphylococcus aureus growth and type 5 capsular polysaccharide production in synthetic media. | Appl Environ Microbiol | 1991 | https://conductscience.org/library/papers/2014996 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3125849
GET https://conductscience.org/api/papers/v1/3125849/cited_by?page=2